Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,326 shares at $16.94 ($22,462)
  2. 4 Open-market sale CEO sold 11,427 shares at $16.94 ($193,573)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale CEO sold 26,574 shares at $17.87 ($474,877)
  5. 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 2,568 shares at $17.87 ($45,890)
  6. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,790 shares at $17.87 ($31,987)
  7. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 2,716 shares at $17.87 ($48,535)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 5,140 shares at $17.90 ($92,006)
  10. 4 Open-market sale CEO sold 17,714 shares at $17.90 ($317,081)
  11. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 5,434 shares at $17.90 ($97,269)
  12. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 772 shares at $24.67 ($19,045)
  13. 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 624 shares at $24.67 ($15,394)
  14. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 474 shares at $24.67 ($11,694)
  15. 4 Open-market sale CEO sold 5,577 shares at $24.67 ($137,585)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale CEO sold 3,732 shares at $29.96 ($111,811)
  19. 4 Open-market sale EVP, COO, Head of Commercial sold 731 shares at $29.96 ($21,901)
  20. 4 Open-market sale EVP,General Counsel, Secretary sold 590 shares at $29.96 ($17,676)

Page 5 of 35 · 686 filings